- Projects & figures
- News & Events
- Managing your project
- About ERC
Natural hazard combined with human error is what makes many disasters especially serious. ERC-funded research led by Professor Gian Paolo Cimellaro from Politecnico di Torino in Italy promises to create a new method to assess the performance of critical infrastructures during emergencies that takes into account the human factor.
What is the nature of dark energy? How does it relate to dark matter? These are some of the key open questions in cosmology, which Prof. Luigi Guzzo intends to address in his research. Findings of his DARKLIGHT project, funded by the ERC, could add an important piece to the puzzle of the origin and evolution of the Universe.
What do the Velvet revolution, the transitions in Baltic countries in the 1990s and the Gezi Park protests in Istanbul have in common? Prof. Donatella Della Porta is leading an ambitious project to compare the most relevant democratization processes led by social movements of the last 25 years.
Why should people waste their time executing some repetitive time-consuming everyday tasks which do not require creativity and intellectual capacity? Such a reasoning stands behind Professor Bruno Siciliano’s ERC funded project aiming at the creation of a new generation of service robots.
Will robots ever have the same dexterity as humans? Professor Antonio Bicchi is working on the next-generation of artificial hands that can be programmed to adapt to different tasks and environments. The promising results of his research could have a strong impact on engineering robotics as well as on rehabilitation technologies.
For the first time ever, two ERC grantees, Prof. Luca G. Guidotti and Dr Matteo Iannacone, have observed in vivo how specific white blood cells, so-called cytotoxic T lymphocytes, identify, target and attack liver cells that are infected with the hepatitis B virus. To witness these immune cells in action in real time, the two scientists developed advanced, dynamic imaging techniques. An estimated 240 million people are chronically infected with hepatitis B worldwide. This discovery, published today in the scientific journal Cell, opens new horizons for the development of novel therapies.